{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:15:13Z","timestamp":1772097313202,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008908","name":"Universit\u00e0 degli Studi di Messina","doi-asserted-by":"publisher","award":["J43C22000310006"],"award-info":[{"award-number":["J43C22000310006"]}],"id":[{"id":"10.13039\/501100008908","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008908","name":"Universit\u00e0 degli Studi di Messina","doi-asserted-by":"publisher","award":["ECS00000022"],"award-info":[{"award-number":["ECS00000022"]}],"id":[{"id":"10.13039\/501100008908","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Hepatic encephalopathy (HE) is a severe complication of liver cirrhosis. Although traditionally considered reversible, growing evidence suggests that HE episodes may lead to persistent neuronal damage. This study aimed to evaluate the potential role of neurofilament light chain proteins (NfL) as biomarkers for detecting neuronal injury associated with HE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Between 1 May 2024, and 30 April 2025, 133 patients were consecutively enrolled at the Liver Unit of the University Hospital of Messina. Exclusion criteria were neurological disorders and active alcohol use. Serum NfL concentrations were measured using SIMOA technology. The study design included two phases: 1) evaluation of NfL concentration differences across the study population, 2) analysis of correlations between NfL levels and clinical\/biochemical parameters routinely used for HE diagnosis [West Haven criteria, ammonia levels, Animal Naming Test (ANT)], as well as anthropometric and nutritional indicators (BMI, handgrip strength, calf circumference).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study population (56.4% males; median age 69 years) included 28 non-cirrhotic (21.1%) and 105 cirrhotic patients (78.9%), 34 of them (32.3%) with a diagnosis of HE. Statistical analysis revealed significant differences in NfL levels across the three groups (p = 0.001). ROC curve analysis demonstrated good discriminative ability of NfL for HE detection (p = 0.001, Area Under the Curve = 0.753). Significant correlations were observed between NfL levels and ANT scores (p = 0.001), West Haven grade (p = 0.05), ammonia levels (p = 0.021), low BMI (p = 0.009), reduced handgrip strength (p = 0.008) and calf circumference &amp;lt;31 cm (p = 0.043).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NfL is a promising biomarker for HE. Its use in clinical practice may improve early detection and stratification of HE severity in cirrhotic patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmolb.2026.1744194","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:37:58Z","timestamp":1772095078000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy"],"prefix":"10.3389","volume":"13","author":[{"given":"Clelia","family":"Asero","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina","place":["Messina, Italy"]},{"name":"Division of Medicine and Hepatology, University Hospital of Messina","place":["Messina, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Polito","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina","place":["Messina, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Stella","family":"Franz\u00e9","sequence":"additional","affiliation":[{"name":"Division of Medicine and Hepatology, University Hospital of Messina","place":["Messina, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Battaglia","sequence":"additional","affiliation":[{"name":"Division of Medicine and Hepatology, University Hospital of Messina","place":["Messina, Italy"]},{"name":"Section of Gastroenterology and Hepatology, PROMISE, University of Palermo","place":["Palermo, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Ligresti","sequence":"additional","affiliation":[{"name":"Division of Medicine and Hepatology, University Hospital of Messina","place":["Messina, Italy"]},{"name":"Section of Gastroenterology and Hepatology, PROMISE, University of Palermo","place":["Palermo, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Maltese","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina","place":["Messina, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Cacciola","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina","place":["Messina, Italy"]},{"name":"Division of Medicine and Hepatology, University Hospital of Messina","place":["Messina, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u2019Hammed","family":"Aguennouz","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina","place":["Messina, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Macaione","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina","place":["Messina, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/jcm14030672","article-title":"Blood neurofilament light chain and Phospho-Tau 181 in subjects with mild cognitive impairment due to age-related hearing loss","volume":"14","author":"Alberti","year":"2025","journal-title":"J. Clin. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of liver diseases","volume":"61","year":"2014","journal-title":"J. Hepatol. Settembre"},{"key":"B3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"100510","DOI":"10.1016\/j.jhepr.2022.100510","article-title":"Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death","volume":"4","author":"Angelova","year":"2022","journal-title":"JHEP Rep. Innov. Hepatol. Agosto"},{"key":"B5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.14218\/JCTH.2024.00413","article-title":"Evaluation of plasma neurodegenerative biomarkers for diagnosing minimal hepatic encephalopathy and predicting overt hepatic encephalopathy in Chinese patients with hepatic cirrhosis","volume":"13","author":"Cheng","year":"2025","journal-title":"J. Clin. Transl. Hepatol. 28 Gennaio"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100352","DOI":"10.1016\/j.jhepr.2021.100352","article-title":"The neurogliovascular unit in hepatic encephalopathy","volume":"3","author":"Claeys","year":"2021","journal-title":"JHEP Rep. Innov. Hepatol. Ottobre"},{"key":"B7","doi-asserted-by":"publisher","first-page":"101740","DOI":"10.1016\/j.aohep.2024.101740","article-title":"Brain reserve in hepatic encephalopathy: pathways of damage and preventive strategies through lifestyle and therapeutic interventions","volume":"30","author":"Cordova-Gallardo","year":"2025","journal-title":"Ann. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis. Age ageing","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Gennaio"},{"key":"B9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"101496","DOI":"10.1016\/j.aohep.2024.101496","article-title":"Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis","volume":"29","author":"de Wit","year":"2024","journal-title":"Ann. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cld.2020.01.001","article-title":"Epidemiology of hepatic encephalopathy","volume":"24","author":"Elsaid","year":"2020","journal-title":"Clin. Liver Dis. Maggio"},{"key":"B12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical Practice Guidelines: Management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J. Hepatol. Luglio"},{"key":"B13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","year":"2019","journal-title":"J. Hepatol. Gennaio"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.3390\/ijms241914727","article-title":"Neurofilament light chain protein in plasma and extracellular vesicles is associated with minimal hepatic encephalopathy and responses to rifaximin treatment in cirrhotic patients","volume":"24","author":"Fiorillo","year":"2023","journal-title":"Int. J. Mol. Sci. 29 Settembre"},{"key":"B15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11011-024-01512-7","article-title":"Ammonia and beyond \u2013 biomarkers of hepatic encephalopathy","volume":"40","author":"Gallego","year":"","journal-title":"Metab. Brain Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11011-24-01512-7","article-title":"Ammonia and beyond - biomarkers of hepatic encephalopathy","volume":"40","author":"Gallego","year":"","journal-title":"Metab. Brain Dis. 15 Gennaio"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/jpm11111090","article-title":"Artificial intelligence and its application to minimal hepatic encephalopathy diagnosis","volume":"11","author":"Gazda","year":"2021","journal-title":"J. Pers. Med. 26 Ottobre"},{"key":"B18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jceh.2018.05.003","article-title":"Hepatic encephalopathy and Astrocyte senescence","volume":"8","author":"G\u00f6rg","year":"2018","journal-title":"J. Clin. Exp. Hepatol. Settembre"},{"key":"B19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3350\/cmh.2019.0015","article-title":"Sarcopenia: ammonia metabolism and hepatic encephalopathy","volume":"25","author":"Jindal","year":"2019","journal-title":"Clin. Mol. Hepatol. Settembre"},{"key":"B20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3350\/cmh.2023.0024","article-title":"Hepatorenal syndrome: current concepts and future perspectives","volume":"29","author":"Jung","year":"2023","journal-title":"Clin. Mol. Hepatol. Ottobre"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e00419","DOI":"10.14309\/ctg.0000000000000419","article-title":"Association between Serum levels of neurofilament light chains and minimal hepatic encephalopathy in patients with liver cirrhosis","volume":"12","author":"Labenz","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jceh.2018.04.007","article-title":"Hepatic encephalopathy and sarcopenia: two faces of the same metabolic alteration","volume":"9","author":"Lattanzi","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2391955","DOI":"10.1080\/0886022X.2024.2391955","article-title":"J-shaped relationship of serum neurofilament light chain with urinary albumin excretion in US adults: NHANES 2013-2014. Ren Fail","volume":"46","author":"Liu","year":"2024","journal-title":"Dicembre"},{"key":"B24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1155\/2015\/967683","article-title":"Renal impairment in cirrhosis unrelated to hepatorenal syndrome","volume":"29","author":"Low","year":"2015","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2427178","DOI":"10.1080\/0886022X.2024.2427178","article-title":"Association between serum neurofilament light chain levels and chronic kidney disease: a cross-sectional population-based study from the National Health and Nutrition Examination Survey (2013-2014 cycle)","volume":"46","author":"Lu","year":"2024","journal-title":"Ren. Fail. Dicembre"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.3748\/wjg.v29.i19.2905","article-title":"Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: evidence and uncertainties","volume":"29","author":"Marrone","year":"2023","journal-title":"World J. Gastroenterol. 21 Maggio"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3748\/wjg.v30.i10.1313","article-title":"Optimizing nutrition in hepatic cirrhosis: a comprehensive assessment and care approach","volume":"30","author":"Mendez-Guerrero","year":"2024","journal-title":"World J. Gastroenterol. 14 Marzo"},{"key":"B28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL Clinical Practice Guidelines on the management of hepatic encephalopathy","volume":"77","author":"Montagnese","year":"2022","journal-title":"J. Hepatol. 1 Settembre"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.3748\/wjg.v25.i35.5257","article-title":"Sarcopenia and cognitive impairment in liver cirrhosis: a viewpoint on the clinical impact of minimal hepatic encephalopathy","volume":"25","author":"Nardelli","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1007\/s11064-021-03372-4","article-title":"Hepatic encephalopathy: from metabolic to neurodegenerative","volume":"46","author":"Ochoa-Sanchez","year":"2021","journal-title":"Neurochem. Res. Ottobre"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","article-title":"Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy","volume":"73","author":"Rose","year":"2020","journal-title":"J. Hepatol. Dicembre"},{"key":"B32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cld.2021.01.008","article-title":"Diagnosis and management of hepatic encephalopathy","volume":"25","author":"Rudler","year":"2021","journal-title":"Clin. Liver Dis. Maggio"},{"key":"B33","doi-asserted-by":"publisher","first-page":"100904","DOI":"10.1016\/j.jhepr.2023.100904","article-title":"Multiple ammonia-induced episodes of hepatic encephalopathy provoke neuronal cell loss in bile-duct ligated rats","volume":"5","author":"Tamnanloo","year":"2023","journal-title":"JHEP Rep. Innov. Hepatol. Dicembre"},{"key":"B34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13195-022-01134-0","article-title":"Association of neurofilament light chain with renal function: mechanisms and clinical implications","volume":"14","author":"Tang","year":"2022","journal-title":"Alzheimers Res. Ther. 16 Dicembre"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/acn3.51676","article-title":"Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface","volume":"9","author":"Vermunt","year":"2022","journal-title":"Ann. Clin. Transl. Neurol. Novembre"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1744194\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:37:59Z","timestamp":1772095079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1744194\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":35,"alternative-id":["10.3389\/fmolb.2026.1744194"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1744194","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"article-number":"1744194"}}